tibolone has been researched along with Endometrial Neoplasms in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (9.68) | 18.2507 |
| 2000's | 23 (74.19) | 29.6817 |
| 2010's | 5 (16.13) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Løkkegaard, ECL; Mørch, LS | 1 |
| Kang, SB; Lee, SJ; Park, DC; Yeo, SG | 1 |
| Bilezikian, J; Christiansen, C; Cummings, SR; Delmas, PD; Eastell, R; Ettinger, B; Grobbee, DE; Johnson, S; Kenemans, P; Kerzberg, EM; Kloosterboer, L; Mol-Arts, M; Mosca, L; Seifert, W; Stathopoulos, V; Verweij, P; Zanchetta, J | 1 |
| Cummings, SR; Ettinger, B; Johnson, SR; Kenemans, P; Mol-Arts, M; Seifert, W; Van Os, S; Verweij, PJ | 1 |
| Fu, R; Griffin, JC; Humphrey, L; Nelson, HD; Nygren, P; Smith, ME | 1 |
| Ivanov, C | 1 |
| Allen, NE; Amiano, P; Bakken, K; Barricarte, A; Bendinelli, B; Bergmann, M; Bueno-de-Mesquita, HB; Chabbert-Buffet, N; Chirlaque, MD; Clavel-Chapelon, F; Dossus, L; Duell, EJ; Fabre, A; Fedirko, V; Fournier, A; Gavrilyuk, O; Kaaks, R; Key, TJ; Khaw, KT; Krogh, V; Lund, E; Michaud, DS; Molina-Montes, ME; Mouw, T; Olsen, A; Onland-Moret, NC; Overvad, K; Panico, S; Redondo, ML; Riboli, E; Rinaldi, S; Sacerdote, C; Schuetze, M; Tjønneland, A; Tsilidis, KK; Tumino, R; van Duijnhoven, FJ; van Gils, CH; Wareham, N | 1 |
| Arteaga-Gómez, AC; Castellanos-Barroso, G; Colin-Valenzuela, A; García-Vargas, J; Márquez-Acosta, G; Reyes-Muñoz, E | 1 |
| Eyster, KM; Hansen, KA | 1 |
| Karakus, C; Simsek, T; Trak, B | 1 |
| Blok, LJ; Burger, CW; De Gooyer, ME; De Ruiter, PE; Gielen, SC; Grootegoed, JA; Hanekamp, EE; Kloosterboer, HJ; Kühne, EC; Smid-Koopman, E | 1 |
| Contreras, L; Rodriguez, T; Sahid, S; Yazigi, R | 1 |
| Mueck, AO; Seeger, H | 1 |
| Boerstoel-Streefland, M; Hendricks, PT; Wierik, EJ | 1 |
| Blok, LJ; Burger, CW; De Gooyer, ME; Gielen, SC; Hanifi-Moghaddam, P; Kloosterboer, HJ; Moorhouse, M; Sijbers, AM; Smid, M; van Gool, AJ; van Wijk, FH | 1 |
| Bromley, SE; de Vries, CS; Farmer, RD; Thomas, H | 1 |
| Khalil, AM; Nassar, AH; Seoud, MA; Usta, IM | 1 |
| Speroff, L | 1 |
| Carvajal, A; Kato, S; Monso, C; Owen, GI; Pinto, M; Sadarangani, A; Salgado, AM; Vigil, P | 1 |
| Farmer, R | 1 |
| Bourg, F; Jamin, C; Legeai, J; Senoussi, S | 1 |
| Cho, CH; Lee, JK; Lee, JM; Lee, KB | 1 |
| Hillard, TC; Soliman, NF | 1 |
| Kimmig, R; Schmidt, M | 1 |
| Blok, LJ; Burger, CW; Hanifi-Moghaddam, P; Kloosterboer, HJ; Kuhne, EC; Nowzari, D; Ott, MC; Sijmons, B; van der Spek, P; van Ijcken, WF | 1 |
| Archer, DF; den Hollander, W; Ferenczy, A; Gallagher, JC; Helmond, FA; Hendrix, S; Rymer, J; Skouby, S; Stathopoulos, V | 1 |
| Archer, DF; Mirkin, S | 1 |
| Gillmer, MD; Gray, MD; McEwan, HP; Pyper, RJ; Rollason, TP; von Dadelszen, P; Wright, A | 1 |
| Ginsburg, J; Prelevic, GM | 1 |
| Altermatt, HJ; Bersinger, NA; Birkhaeuser, MH; Haenggi, W | 1 |
| Birkhäuser, MH | 1 |
5 review(s) available for tibolone and Endometrial Neoplasms
| Article | Year |
|---|---|
Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer.
Topics: Breast Neoplasms; Endometrial Neoplasms; Estrogen Receptor Modulators; Female; Fractures, Bone; Humans; Norpregnenes; Raloxifene Hydrochloride; Stroke; Tamoxifen; Thromboembolism | 2009 |
Hormone therapy after endometrial cancer.
Topics: Age Distribution; Aged; Chemotherapy, Adjuvant; Cyclohexanols; Dose-Response Relationship, Drug; Drug Administration Schedule; Endometrial Neoplasms; Estrogens; Female; Germany; Hormone Replacement Therapy; Humans; Hysterectomy; Incidence; Middle Aged; Neoplasm Staging; Norpregnenes; Progestins; Raloxifene Hydrochloride; Risk Assessment; Survival Analysis; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Hormone replacement therapy in women with past history of endometriosis.
Topics: Adult; Aged; Endometrial Neoplasms; Endometriosis; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Hysterectomy; Menopause; Middle Aged; Norpregnenes; Risk Factors | 2006 |
[The benefits and risks of hormonal replacement therapy--an update].
Topics: Adult; Age Factors; Aged; Breast Neoplasms; Cardiovascular Diseases; Colonic Neoplasms; Dementia; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Humans; Meta-Analysis as Topic; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Ovarian Neoplasms; Primary Prevention; Progestins; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Stroke; Thromboembolism; Time Factors | 2006 |
[Indications for hormone replacement therapy].
Topics: Aged; Alzheimer Disease; Anabolic Agents; Breast Neoplasms; Cardiovascular Diseases; Contraindications; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Progestins; Raloxifene Hydrochloride; Risk; Selective Estrogen Receptor Modulators; Thrombosis | 2000 |
6 trial(s) available for tibolone and Endometrial Neoplasms
| Article | Year |
|---|---|
The effects of tibolone in older postmenopausal women.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Bone Density; Breast Neoplasms; Colonic Neoplasms; Double-Blind Method; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Radiography; Risk; Spinal Fractures; Stroke | 2008 |
Endometrial effects of tibolone in elderly, osteoporotic women.
Topics: Aged; Bone Density Conservation Agents; Carcinoma, Endometrioid; Endometrial Neoplasms; Endometrium; Estrogen Replacement Therapy; Female; Humans; Hyperplasia; Metrorrhagia; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal | 2008 |
Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system.
Topics: Administration, Cutaneous; Aged; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Polyps; Postmenopause; Progesterone Congeners; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms | 2002 |
Tibolone and endometrial cancer: a cohort and nested case-control study in the UK.
Topics: Aged; Case-Control Studies; Cohort Studies; Data Interpretation, Statistical; Demography; Endometrial Neoplasms; Female; Hormone Replacement Therapy; Humans; Incidence; Male; Middle Aged; Norpregnenes; Odds Ratio; Time Factors; United Kingdom | 2005 |
Endometrial effects of tibolone.
Topics: Aged; Carcinoma; Cohort Studies; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Pain; Uterine Hemorrhage | 2007 |
Placental protein 14 (PP14) does not predict endometrial status under hormone replacement therapy.
Topics: Biopsy; Dydrogesterone; Endometrial Neoplasms; Endometrium; Enzyme-Linked Immunosorbent Assay; Estradiol; Estrogen Replacement Therapy; Female; Glycodelin; Glycoproteins; Humans; Hyperplasia; Middle Aged; Norpregnenes; Postmenopause; Pregnancy Proteins | 1997 |
20 other study(ies) available for tibolone and Endometrial Neoplasms
| Article | Year |
|---|---|
Tibolone and risk of gynecological hormone sensitive cancer.
Topics: Aged; Denmark; Endometrial Neoplasms; Estrogen Receptor Modulators; Female; Humans; Incidence; Middle Aged; Norpregnenes; Ovarian Neoplasms | 2018 |
Attitudes and practices of Korean gynecologists towards hormone replacement therapy in endometrial cancer survivors.
Topics: Adenocarcinoma; Adult; Attitude of Health Personnel; Endometrial Neoplasms; Estrogen Receptor Modulators; Female; Gynecology; Hormone Replacement Therapy; Humans; Hysterectomy; Male; Menopause, Premature; Middle Aged; Neoplasm Grading; Neoplasm Staging; Norpregnenes; Ovariectomy; Practice Patterns, Physicians'; Republic of Korea; Salpingectomy; Surveys and Questionnaires; Time Factors | 2013 |
[Modern tendencies in HRT of patients treated for endometrial cancer].
Topics: Endometrial Neoplasms; Endometrium; Estrogens; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Norpregnenes; Progestins; Risk Factors | 2009 |
Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation Into Cancer and Nutrition.
Topics: Age Factors; Aged; Body Mass Index; Cohort Studies; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Europe; Female; Humans; Incidence; Middle Aged; Norpregnenes; Postmenopause; Proportional Hazards Models; Retrospective Studies; Risk Factors | 2010 |
[Hormone therapy effect in postmenopausal women with history of endometrial cancer].
Topics: Adenocarcinoma; Adult; Carcinoma, Adenosquamous; Carcinoma, Endometrioid; Comorbidity; Diabetes Mellitus, Type 2; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Hypertension; Middle Aged; Neoplasm Staging; Norpregnenes; Postmenopause; Recurrence; Retrospective Studies; Smoking | 2011 |
What happened to WHI: menopausal hormonal therapy in 2012.
Topics: Atrophy; Breast Neoplasms; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norpregnenes; Patient Selection; Raloxifene Hydrochloride; Vagina | 2012 |
Progestogenic effects of tibolone on human endometrial cancer cells.
Topics: Cell Division; Endometrial Neoplasms; Female; Fibronectins; Gene Expression Regulation; Humans; Insulin-Like Growth Factor Binding Protein 3; Medroxyprogesterone Acetate; Norpregnenes; Progesterone; Progestins; Receptors, Progesterone; Tumor Cells, Cultured | 2003 |
Carcinoma of the endometrium in patients treated with tibolone.
Topics: Adenocarcinoma; Aged; Anabolic Agents; Androgen Antagonists; Endometrial Neoplasms; Estrogen Receptor Modulators; Female; Humans; Middle Aged; Norpregnenes | 2004 |
Clinical background of women prescribed tibolone or combined estrogen + progestogen therapies: a UK MediPlus study.
Topics: Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Endometrial Neoplasms; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norgestrel; Norpregnenes; Practice Patterns, Physicians'; Registries; Retrospective Studies; Risk Factors; United Kingdom | 2004 |
Molecular portrait of the progestagenic and estrogenic actions of tibolone: behavior of cellular networks in response to tibolone.
Topics: Adenocarcinoma; Cell Differentiation; Cell Division; Cell Line, Tumor; Endometrial Neoplasms; Estradiol; Estrogen Receptor Modulators; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Nerve Net; Norpregnenes; Progestins; Transcription, Genetic | 2005 |
Endometrial adenocarcinoma after prolonged tibolone therapy.
Topics: Adenocarcinoma; Brachytherapy; Diagnosis, Differential; Drug Administration Schedule; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Postmenopause; Uterine Hemorrhage | 2005 |
Endometrial cancer--surprising reports.
Topics: Clomiphene; Cohort Studies; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Multicenter Studies as Topic; Norpregnenes; Retrospective Studies; Risk Factors; Selective Estrogen Receptor Modulators | 2005 |
In vivo and in vitro estrogenic and progestagenic actions of Tibolone.
Topics: Biomarkers, Tumor; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Endometrial Neoplasms; Endometrium; Estrogen Receptor Modulators; Estrogens; Female; Gene Expression Regulation, Neoplastic; Humans; Norpregnenes; Progestins; Time Factors; Ultrasonography | 2005 |
The Million Women Study--is it believable?
Topics: Bias; Breast Neoplasms; Data Interpretation, Statistical; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Mass Media; Norpregnenes; Research Design; United Kingdom | 2005 |
[Is the clinical profile of women treated with tibolone similar to that of women receiving a classical estrogen-progestogen therapy? Data from a nationwide survey in France].
Topics: Age Factors; Aged; Breast Neoplasms; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; France; Health Surveys; Humans; Middle Aged; Norpregnenes; Postmenopause; Risk Factors; Selection Bias | 2006 |
Endometrial cancer patients and tibolone: a matched case-control study.
Topics: Antineoplastic Agents, Hormonal; Case-Control Studies; Disease-Free Survival; Endometrial Neoplasms; Female; Humans; Middle Aged; Norpregnenes; Retrospective Studies; Survival Rate | 2006 |
The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen-and progesterone-responsive endometrial cancer cell line.
Topics: Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Estrogens; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norpregnenes; Oligonucleotide Array Sequence Analysis; Progesterone; Transcription, Genetic | 2006 |
Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
Topics: Adenocarcinoma; Angiopoietin-1; Cell Line, Tumor; Contraceptive Agents, Female; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Receptor Modulators; Female; Humans; Medroxyprogesterone Acetate; Norpregnenes; Receptor, TIE-2; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Tumor Necrosis Factor-alpha | 2007 |
Endometrial hyperplasia and adenocarcinoma during tibolone (Livial) therapy.
Topics: Adenocarcinoma; Aged; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Menopause; Middle Aged; Norpregnenes | 1994 |
Cause of vaginal bleeding in postmenopausal women taking tibolone.
Topics: Aged; Aged, 80 and over; Anabolic Agents; Carcinoma in Situ; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estrogen Replacement Therapy; Estrogens; Female; Humans; Hysteroscopy; Leiomyoma; Middle Aged; Norpregnenes; Polyps; Postmenopause; Time Factors; Ultrasonography, Doppler; Uterine Hemorrhage; Uterine Neoplasms | 1996 |